Capability and feasibility

We strongly believe that careful selection and evaluation of Investigators is critical to the successful enrollment and quality of our studies. Consequently, we have created a sophisticated database of potential Investigators in addition to implementing a proprietary system to evaluate their performance at the end of each study.

What differentiates Cromos from our competitors is a unique method of site selection that is based on:

  • Experience with more than 1000 sites in most therapeutic areas since 2004
  • Electronic Internal Investigators/Sites database (detailed contact information for 2,109 Investigators and 1,711 Study Sites)
  • Along with full clinical trial management and support in North America, we are proud of our well-established operating activities in Central and Eastern Europe (Bulgaria, Croatia, Czech Republic, Estonia, Latvia, Lithuania, Hungary, Poland, Romania, Slovakia, Slovenia) and Eurasian region (Georgia, Belarus, Armenia, Moldova, Kazakhstan, Uzbekistan)
  • Collaboration with validated partners in Asia Pacific and South America regions
  • Proprietary and customizable Electronic Feasibility Questionnaire
  • Investment into long-term relationship with investigators
  • Active consultations with country-specific key opinion leaders
  • Working with leading medical centers and tertiary hospitals guarantees high quality of clinical research and rapid recruitment
  • Mapping of competitive trials helps avoid slow recruitment

If you would like to conduct a feasibility or capability study, just contact the Head of our Feasibility Division.


Cromos Pharma delivers a wide range of specialized clinical research services to help pharmaceutical and biotechnology companies accelerate drug development and bring treatments to market faster. Our flexible and tailored solutions cover the entire lifecycle of product development and can be adapted according to the size and scale of each individual project.